アブストラクト
| Title | 1 呼吸器疾患における呼吸困難の発生機序とその対策 |
|---|---|
| Subtitle | 特集 進化する呼吸器疾患のリハビリテーション医療 |
| Authors | 金崎雅史* |
| Authors (kana) | |
| Organization | *東京国際大学医療健康学部理学療法学科 |
| Journal | The Japanese Journal of Rehabilitation Medicine |
| Volume | 60 |
| Number | 2 |
| Page | 96-101 |
| Year/Month | 2023 / 2 |
| Article | 報告 |
| Publisher | 日本リハビリテーション医学会 |
| Abstract | 「要旨」呼吸困難は複数の感覚と情動的側面から構成される. また, 呼吸困難は身体活動やQOL, 医療費, 死亡率と関連することが知られ, そのメカニズムの把握と介入は重要である. しかしながら, 多くの患者において, 適切な治療でも, なお呼吸困難が残存していることが問題となっており, 普段の生活において呼吸困難に関するunmet needが存在することが示唆されている. 慢性閉塞性肺疾患における呼吸困難において, 気管支拡張薬が有用であるが, 呼吸困難を征圧するに至っていない. また, モルヒネによる呼吸困難の緩和においても, 一致した見解が得られておらず. さらなる介入方策が求められている. 一方, 携帯型扇風機による顔面への送風やメントールによる呼吸困難の緩和は比較的容易に利用でき, その有効性が近年報告されている. 加えて, サルコペニアを合併する慢性閉塞性肺疾患患者においては, 浅速呼吸が呼吸困難の悪化の要因となっており, 吸気筋力トレーニングが有用であることが示唆されている. |
| Practice | 医療技術 |
| Keywords | 呼吸困難, 吸気神経ドライブ, サルコペニア, L-メントール嗅覚刺激 |
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
参考文献
- 1) Currow DC, Plummer JL, Crockett A, Abernethy AP:A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 2009;38:533-545
- 2) van Mourik Y, Rutten FH, Moons KG, Bertens LC, Hoes AW, Reitsma JB:Prevalence and underlying causes of dyspnoea in older people:a systematic review. Age Ageing 2014;43:319-326
- 3) Nishimura K, Izumi T, Tsukino M, Oga T:Dysp-nea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434-1440
- 4) 金崎雅史研究室. Available from URL:https://kanezakilabo.com/
- 5) Elbehairy AF, Quint JK, Rogers J, Laffan M, Polkey MI, Hopkinson NS:Patterns of breathlessness and associated consulting behaviour:results of an on-line survey. Thorax 2019;74:814-817
残りの18件を表示する
- 6) Johnson MJ, Yorke J, Hansen-Flaschen J, Lansing R, Ekstrom M, Similowski T, Currow DC:Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J 2017;49:1602277
- 7) Faisal A, Alghamdi BJ, Ciavaglia CE, Elbehairy AF, Webb KA, Ora J, Alberto Neder J, O'Donnell DE:Common mechanisms of dyspnea in chronic inter-stitial and obstructive lung disorders. Am J Respir Crit Care Med 2016;193:299-309
- 8) Jolley CJ, Moxham J:A physiological model of patient-reported breathlessness during daily activi-ties in COPD. Eur Respir Rev 2009;18:66-79
- 9) Jolley CJ, Moxham J:Dyspnea Intensity:A Pa-tient-reported Measure of Respiratory Drive and Disease Severity. Am J Respir Crit Care Med 2016;193:236-238
- 10) Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, Mahler DA, Meek PM, O'Donnell DE:An official American Thoracic Soci-ety statement:Update on the mechanisms, assess-ment, and management of dyspnea. Am J Respir Crit Care Med 2012;185:435-452
- 11) Sepulveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS:Diagnosis, prevalence, and clinical impact of sarcopenia in COPD:a systemat-ic review and meta-analysis. J Cachexia Sarcopenia Muscle 2020;11:1164-1176
- 12) Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H:Asian Working Group for Sar-copenia:2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 2020;21:300-307.e2
- 13) Kanezaki M, Terada K, Tanabe N, Shima H, Hamakawa Y, Sato S:Effects of Sarcopenia on Ven-tilatory Behavior and the Multidimensional Nature of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease. J Am Med Dir Assoc 2021;22:827-833
- 14) Hanada M, Sakamoto N, Ishimoto H, Kido T, Miyamura T, Oikawa M, Nagura H, Takeuchi R, Kawazoe Y, Sato S, Hassan SA, Ishimatsu Y, Takahata H, Mukae H, Kozu R:A comparative study of the sarcopenia screening in older patients with interstitial lung disease. BMC Pulm Med 2022;22:45
- 15) Oba Y, Sarva ST, Dias S:Efficacy and safety of long-acting beta-agonist/long-acting muscarinic an-tagonist combinations in COPD:a network meta-analysis. Thorax 2016;71:15-25
- 16) Verberkt CA, van den Beuken-van Everdingen MHJ, Schols J, Hameleers N, Wouters EFM, Janssen DJA:Effect of Sustained-Release Morphine for Re-fractory Breathlessness in Chronic Obstructive Pul-monary Disease on Health Status:A Randomized Clinical Trial. JAMA Intern Med 2020;180:1306-1314
- 17) Currow D, Louw S, McCloud P, Fazekas B, Plummer J, McDonald CF, Agar M, Clark K, McCaffrey N, Ekstrom MP;Australian National Palliative Care Clinical Studies Collaborative(PaCCSC):Regular, sustained-release morphine for chronic breathlessness:a multicentre, double-blind, randomised, placebo-controlled trial. Thorax 2020;75:50-56
- 18) Galbraith S, Fagan P, Perkins P, Lynch A, Booth S:Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010;39:831-838
- 19) Hui D, Hernandez F, Urbauer D, Thomas S, Lu Z, Elsayem A, Bruera E:High-Flow Oxygen and High-Flow Air for Dyspnea in Hospitalized Patients with Cancer:A Pilot Crossover Randomized Clini-cal Trial. Oncologist 2021;26:e883-e892
- 20) Plevkova J, Kollarik M, Poliacek I, Brozmanova M, Surdenikova L, Tatar M, Mori N, Canning BJ:The role of trigeminal nasal TRPM8-expressing afferent neurons in the antitussive effects of menthol. J Appl Physiol(1985)2013;115:268-274
- 21) Kanezaki M, Terada K, Ebihara S:Effect of Olfac-tory Stimulation by L-Menthol on Laboratory-In-duced Dyspnea in COPD. Chest 2020;157:1455-1465
- 22) Kanezaki M, Ebihara S:Effect of the cooling sensa-tion induced by olfactory stimulation by L-menthol on dyspnoea:a pilot study. Eur Respir J 2017;49:1601823
- 23) Charususin N, Gosselink R, McConnell A, Demeyer H, Topalovic M, Decramer M, Langer D:Inspirato-ry muscle training improves breathing pattern during exercise in COPD patients. Eur Respir J 2016;47:1261-1264
